106
Views
4
CrossRef citations to date
0
Altmetric
Perspectives

Computational methods to support high-content screening: from compound selection and data analysis to postulating target hypotheses

, , &
Pages 5-13 | Published online: 15 Dec 2008

Bibliography

  • Bertelsen M, Sanfridson A. Inflammatory pathway analysis using a high content screening platform. Assay Drug Dev Technol 2005;3(3):261-71
  • Rines DR, Tu B, Mariglia L, et al. High-content screening of functional genomic libraries. Methods Enzymo 2006;414:530-65
  • Lang PT, Kuntz ID, Maggiora GM, et al. Evaluating the high-throughput screening computations. J Biomol Screen 2005;10(7):649-52
  • Parker CN. McMaster University data-mining and docking competition: computational models on the catwalk. J Biomol Screen 2005;10(7):647-8
  • Fergus S, Bender A, Spring DR. Assessment of structural diversity in combinatorial synthesis. Curr Op Chem Biol 2005;9(3):304-9
  • Lajiness MS. Dissimilarity-based compound selection techniques. Perspect Drug Disc Design 1997;7/8:65-84
  • Teig SL. Informative Libraries are More Useful than Diverse Ones. J Biomol Screen 1998;3(2):85-8
  • Spencer RW. Diversity analysis in high throughput screening. J Biomol Screen 1997;2:69-70
  • Bajorath J. Integration of virtual and high-throughput screening. Nat Rev Drug Discov 2002;1(11):882-94
  • Bender A, Mussa HY, Glen RC, et al. Molecular similarity searching using atom environments, information-based feature selection, and a naive bayesian classifier. J Chem Inf Comput Sci 2004;44(1):170-8
  • Engels MF, Venkatarangan P. Smart screening: approaches to efficient HTS. Curr Opin Drug Discov Devel 2001;4(3):275-83
  • Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004;3(11):935-49
  • Bender A, Glen RC. Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2(22):3204-18
  • Johnson M, Maggiora GM, eds. Concepts and Application of Molecular Similarity. New York: John Wiley & Sons 1990
  • Schreyer SK, Parker CN, Maggiora GM. Data shaving: a focused screening approach. J Chem Inf Comput Sci 2004;44(2):470-9
  • Crisman TJ, Jenkins JL, Parker CN, et al. “Plate cherry picking”: a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection. J Biomol Screen 2007;12(3):320-7
  • Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7:R100
  • Skylar O, Huber W, Smith M. EBImage: Image analysis and image processing toolkit for R. 2.2.0 edition: Eur Bioinform Inst 2007
  • Denner P, Schmalowsky J, Prechtl S. High-content analysis in preclinical drug discovery. Comb Chem High Throughput Screen 2008;11(3):216-30
  • O'Brien P, Haskins JR. In vitro cytotoxicity assessment. Methods Mol Biol 2007;356:415-25
  • Loo LH, Wu LF, Altschuler SJ. Image-based multivariate profiling of drug responses from single cells. Nat Methods 2007;4(5):445-53
  • MacDonald ML, Lamerdin J, Owens S, et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2006;2(6):329-37
  • Tanaka M, Bateman R, Rauh D, et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005;3(5):e128
  • Young DW, Bender A, Hoyt J, et al. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol 2008;4(1):59-68
  • Duerr O, Duval F, Nichols A, et al. Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay. J Biomol Screen 2007;12(8):1042-9
  • Lansing Taylor D, Giuliano KA. Multiplexed high content screening assays create a systems cell biology approach to drug discovery. Drug Discovery Today Technol 2005;2(2):149-54
  • Giuliano KA, Chen YT, Taylor DL. High-content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of P53 activation in the cellular response to anticancer drugs. J Biomol Screen 2004;9(7):557-68
  • Perlman ZE, Slack MD, Feng Y, et al. Multidimensional drug profiling by automated microscopy. Science 2004;306(5699):1194-8
  • Vogt A, Tamewitz A, Skoko J, et al. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 2005;280(19):19078-86
  • Adams CL, Kutsyy V, Coleman DA, et al. Compound classification using image-based cellular phenotypes. Methods Enzymol 2006;414:440-68
  • Tao CY, Hoyt J, Feng Y. A support vector machine classifier for recognizing mitotic subphases using high-content screening data. J Biomol Screen 2007;12(4):490-6
  • Gillet VJ, Khatib W, Willett P, et al. Combinatorial library design using a multiobjective genetic algorithm. J Chem Inf Comput Sci 2002;42(2):375-85
  • Low J, Stancato L, Lee J, et al. Prioritizing hits from phenotypic high-content screens. Curr Opin Drug Discov Devel 2008;11(3):338-45
  • Smellie A, Wilson CJ, Ng SC. Visualization and interpretation of high content screening data. J Chem Inf Model 2006;46(1):201-7
  • Goldberg IG, Allan C, Burel JM, et al. The Open Microscopy Environment (OME) Data Model and XML file: open tools for informatics and quantitative analysis in biological imaging. Genome Biol 2005;6(5):R47
  • Available from: http://www.ravkin.net/SBS/ Invitation-Algorithm-Comparison.htm
  • Jenkins JL, Bender A, Davies JW. In silico target fishing: Predicting biological targets from chemical structure. Drug Discov Today Technol 2007;3:413-21
  • Nettles JH, Jenkins JL, Bender A, et al. Bridging chemical and biological space: “target fishing” using 2D and 3D molecular descriptors. J Med Chem 2006;49(23):6802-10
  • Maggiora GM. On outliers and activity cliffs--why QSAR often disappoints. J Chem Inf Model 2006;46(4):1535

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.